Inventor · San Diego, CA, US

Xian-Ping Lu

12Patents
5h-index
24Co-inventors
66Inventor score

Filing activity: Apr 14, 1999 → Oct 23, 2018

Most-cited inventions

PatentTitleAreaCited byStatus
US6127415A Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents Human Necessities 21 Expired
US6462064B1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias Human Necessities 16 Expired
US7244751B2 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity Chemistry; Metallurgy 13 Expired
US7550490B2 Benzamide derivatives as histone deacetylase inhibitors with potent differentiation and anti-proliferation activity Chemistry; Metallurgy 11 Active
US8211901B2 Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors Chemistry; Metallurgy 8 Active
US7268157B2 Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity Chemistry; Metallurgy 2 Expired
US6825226B2 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias Human Necessities 1 Expired
US7863315B2 2-indolinone derivatives as selective histone deacetylase inhibitors Chemistry; Metallurgy 0 Active
US8158656B2 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors Human Necessities 0 Active
US11739001B2 Molecular sieve composition, process of preparing same and use thereof Emerging Cross-Sectional Technologies 0 Active
US8178577B2 Tricyclic derivatives as potent and selective histone deacetylase inhibitors Chemistry; Metallurgy 0 Active
US7192970B2 Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity Chemistry; Metallurgy 0 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.